EUR 15.35
(3.02%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 50.89 Million EUR | 3.46% |
2022 | 49.19 Million EUR | 32.45% |
2021 | 37.14 Million EUR | -6.02% |
2020 | 39.52 Million EUR | -4.14% |
2019 | 41.23 Million EUR | 20.62% |
2018 | 34.18 Million EUR | 3.87% |
2017 | 32.9 Million EUR | 5.71% |
2016 | 31.12 Million EUR | 8.2% |
2015 | 28.77 Million EUR | -8.49% |
2014 | 31.44 Million EUR | 24.26% |
2013 | 25.3 Million EUR | 58.08% |
2012 | 16 Million EUR | -13.01% |
2011 | 18.4 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 57.14 Million EUR | 12.27% |
2024 Q2 | 57.53 Million EUR | 0.68% |
2023 Q3 | 63.53 Million EUR | 8.5% |
2023 Q4 | 50.89 Million EUR | -19.89% |
2023 Q1 | 50.63 Million EUR | 2.93% |
2023 Q2 | 58.55 Million EUR | 15.64% |
2023 FY | 50.89 Million EUR | 3.46% |
2022 Q4 | 49.19 Million EUR | -4.72% |
2022 Q1 | 42.35 Million EUR | 14.04% |
2022 FY | 49.19 Million EUR | 32.45% |
2022 Q3 | 51.63 Million EUR | 6.01% |
2022 Q2 | 48.7 Million EUR | 14.98% |
2021 Q1 | 42.43 Million EUR | 7.37% |
2021 FY | 37.14 Million EUR | -6.02% |
2021 Q4 | 37.14 Million EUR | -13.56% |
2021 Q3 | 42.97 Million EUR | -5.35% |
2021 Q2 | 45.39 Million EUR | 6.98% |
2020 Q2 | 44.45 Million EUR | 1.15% |
2020 FY | 39.52 Million EUR | -4.14% |
2020 Q1 | 43.94 Million EUR | 6.59% |
2020 Q4 | 39.52 Million EUR | 1.41% |
2020 Q3 | 38.97 Million EUR | -12.33% |
2019 Q3 | 46.29 Million EUR | -4.54% |
2019 Q4 | 41.23 Million EUR | -10.93% |
2019 FY | 41.23 Million EUR | 20.62% |
2019 Q1 | 42.73 Million EUR | 25.03% |
2019 Q2 | 48.49 Million EUR | 13.46% |
2018 Q3 | 38.52 Million EUR | -10.96% |
2018 Q4 | 34.18 Million EUR | -11.28% |
2018 FY | 34.18 Million EUR | 3.87% |
2018 Q1 | 39.23 Million EUR | 19.22% |
2018 Q2 | 43.27 Million EUR | 10.3% |
2017 Q4 | 32.9 Million EUR | 0.0% |
2017 FY | 32.9 Million EUR | 5.71% |
2017 Q2 | 43.88 Million EUR | 0.0% |
2017 Q1 | - EUR | -100.0% |
2016 Q4 | 31.12 Million EUR | -0.0% |
2016 Q3 | 31.12 Million EUR | -18.58% |
2016 Q2 | 38.23 Million EUR | 0.0% |
2016 Q1 | 38.23 Million EUR | 32.9% |
2016 FY | 31.12 Million EUR | 8.2% |
2015 FY | 28.77 Million EUR | -8.49% |
2015 Q3 | 33.91 Million EUR | -20.49% |
2015 Q1 | 31.03 Million EUR | -1.3% |
2015 Q2 | 42.64 Million EUR | 37.44% |
2015 Q4 | 28.77 Million EUR | -15.16% |
2014 FY | 31.44 Million EUR | 24.26% |
2014 Q3 | 32.71 Million EUR | 0.84% |
2014 Q2 | 32.44 Million EUR | 21.34% |
2014 Q1 | 26.73 Million EUR | 5.66% |
2014 Q4 | 31.44 Million EUR | -3.88% |
2013 Q4 | 25.3 Million EUR | 22.56% |
2013 Q1 | 19.94 Million EUR | 24.6% |
2013 Q2 | 25.9 Million EUR | 29.88% |
2013 Q3 | 20.64 Million EUR | -20.3% |
2013 FY | 25.3 Million EUR | 58.08% |
2012 FY | 16 Million EUR | -13.01% |
2012 Q4 | 16 Million EUR | 0.0% |
2011 FY | 18.4 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Evrofarma SA | 31.13 Million EUR | -63.49% |
Flour Mills Kepenos S.A. | 37.23 Million EUR | -36.677% |
Loulis Food Ingredients S.A. | 98.69 Million EUR | 48.432% |